Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Small molecule pad4 inhibitor and its preparation method and application

A technology of small molecules and inhibitors, applied in the field of small molecule PAD4 inhibitors and its preparation, can solve the problems of lack of oral activity, poor bioavailability, unsatisfactory activity, etc.

Active Publication Date: 2022-05-17
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Based on the small molecule substrate N-benzoyl-L-arginineamide (BAA) of PAD4, researchers have developed a variety of potent and irreversible haloacetamidine PAD4 inhibitors, but there are still lack of oral activity and biological Problems of poor utilization and unsatisfactory activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Small molecule pad4 inhibitor and its preparation method and application
  • Small molecule pad4 inhibitor and its preparation method and application
  • Small molecule pad4 inhibitor and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0079] In the present invention, when R 1 for R 2 for When, the preparation method of described small molecule PAD4 inhibitor comprises the following steps:

[0080] Dissolve the first reaction raw material in tetrahydrofuran, mix the resulting mixture with 1-hydroxybenzotriazole and dicyclohexylcarbodiimide, and perform the first activation, then mix the resulting activation system with benzylamine, and use N- Methylmorpholine adjusts the pH value of the obtained mixed solution to 8-9, performs the first condensation reaction, and obtains the first intermediate product;

[0081] Dissolving the first intermediate product in ethyl acetate, mixing the resulting mixture with HCl in ethyl acetate, and then performing a first hydrolysis reaction to obtain a second intermediate product;

[0082] Dissolving the second reaction raw material in tetrahydrofuran, mixing the resulting mixture with 1-hydroxybenzotriazole and dicyclohexylcarbodiimide, and then performing the second ...

Embodiment 1

[0131] The synthesis of embodiment 1 (3-boronobenzoic acid)-Orn (Cl)-NBzl (ZD-E-2)

[0132] (1) Synthesis of Boc-Orn(Z)-NBzl

[0133] Weight loss method Accurately weigh 3.660g (10mmol) Boc-Orn(Z)-OH and place it in an eggplant bottle, dissolve it with 100mL anhydrous THF until it is colorless, clear and transparent, add a stirrer; under ice bath stirring, add 1.620g (12mmol) 1-hydroxybenzotriazole (HOBt) and 2.472g (12mmol) dicyclohexylcarbodiimide (DCC), after activating 10min, white solid is separated out; Add 1.6mL benzylamine dropwise in eggplant bottle, And use N-methylmorpholine (NMM) to adjust the pH to 8; remove the ice bath, stir and react at room temperature (25°C) for 8h, and use TLC (by volume, the developing agent is CH 2 Cl 2 :CH 3 OH=30:1,R f =0.35) detect the reaction process, observe the disappearance of the raw material point, and judge that the reaction is complete. After the reaction, use a vacuum circulating water pump to filter under reduced pressur...

Embodiment 2

[0142] The synthesis of embodiment 2 (2-boronobenzoic acid)-Orn (Cl)-NBzl (ZD-E-3)

[0143] (1) Synthesis of (2-boronobenzoic acid)-Orn(Z)-NBzl

[0144] The target product was prepared with reference to the method of step (3) in Example 1, except that "3-carboxyphenylboronic acid (3-boronobenzoic acid)" was replaced by "2-carboxyphenylboronic acid (2-boronobenzoic acid)", and finally 1.650 g (65.6%) of the target product (2-boronobenzoic acid)-Orn(Z)-NBzl were obtained as a white solid. ESI-MS(m / z):538.6[M+Cl] - ; 1 H-NMR (300MHz, DMSO-d 6 ): δ(ppm)=8.78(t, J=5.7Hz, 1H), 7.76(dt, J=7.7Hz, 1.9Hz, 1H), 7.57(d, J=7.4Hz, 1H), 7.44(m, 1H),7.41(m,1H),7.38(m,1H),7.30(m,10H),6.88(m,1H),5.01(s,2H),4.28(m,2H),3.97(t,J =6.6Hz, 1H), 3.03(t, J=6.7Hz, 2H), 1.75(m, 2H), 1.50(m, 2H).

[0145] (2) Synthesis of (2-boronobenzoic acid)-Orn-NBzl

[0146] The target product was prepared by referring to the method of step (4) in Example 1, specifically, 1.650g (3.3mmol) (2-boronobenzoic acid)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a molecular PAD4 inhibitor and its preparation method and application, belonging to the technical field of biomedicine. The present invention uses two functional groups to modify the amino acid skeleton, one is NBD-Cl with low polarity and strong fluorescence characteristics, and it can be used for subcellular imaging by modifying the N-terminal of the amino acid skeleton. Small, lacks reaction orthogonality, and has little interference with the biochemical reactions of the organism itself; the other is a tumor-targeted PBA that can bind to the cell membrane by recognizing the cis-diol unit of the glycoprotein. This PBA / cis Diol interactions can also regulate the formation of dynamic covalent bonds by adjusting the pH value or adding competing molecules to achieve a controllable self-assembly system. The small molecule PAD4 inhibitor of the present invention has good oral activity, has inhibitory effect on mouse tumor growth and metastasis, and has therapeutic effect on rat arterial thrombus.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a small molecule PAD4 inhibitor and its preparation method and application. Background technique [0002] Remarkable progress has been made in the fight against cancer in recent years, but it remains a daunting public health challenge. [0003] Post-translational modifications (PTMs) of histones are hallmarks of epigenetic regulation. Studies have shown that the silencing of tumor suppressor genes by epigenetic modifiers is an early event in the process of tumorigenesis. The approval of anticancer drugs targeting histone deacetylases and DNA methyltransferases over the past few decades has highlighted the important role of epigenetics in human disease and suggested that factors controlling gene expression can act as Novel drug targets. Peptidylarginine deiminase 4 (PAD4) is one such target because it has similar effects on gene expression as histone deacetylases. PAD4 act...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F5/02A61K31/69A61P35/00
CPCY02P20/55
Inventor 王玉记王彦明朱迪卢玉阿依江贾翌江王炜
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com